Vysokodoznaya khimioterapiya i autotransplantatsiya pri mnozhestvennoy mielome
Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Н Н Калинин, И А Воробьев, Vera Zherebtsova(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), L S Lyubimova, Е. М. Грецов, K. S. Momotyuk, E Yu Varlamova, Е Н Устинова, Е О Грибанова, N E Mitish, I B Kaplanskaya(National Medical Research Center for Hematology), Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Olga S. Pokrovskaya, N. G. Tyurina
DOAJ (DOAJ: Directory of Open Access Journals)
March 1, 2006
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59